GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (TSE:4502) » Definitions » Net Margin %
中文

Takeda Pharmaceutical Co (TSE:4502) Net Margin %

: 9.51% (As of Dec. 2023)
View and export this data going back to 1949. Start your Free Trial

Net margin is calculated as Net Income divided by its Revenue. Takeda Pharmaceutical Co's Net Income for the three months ended in Dec. 2023 was 円105,720 Mil. Takeda Pharmaceutical Co's Revenue for the three months ended in Dec. 2023 was 円1,111,186 Mil. Therefore, Takeda Pharmaceutical Co's net margin for the quarter that ended in Dec. 2023 was 9.51%.

The historical rank and industry rank for Takeda Pharmaceutical Co's Net Margin % or its related term are showing as below:

TSE:4502' s Net Margin % Range Over the Past 10 Years
Min: -8.2   Med: 6.45   Max: 11.76
Current: 4.28


TSE:4502's Net Margin % is ranked better than
52.01% of 1019 companies
in the Drug Manufacturers industry
Industry Median: 3.77 vs TSE:4502: 4.28

Takeda Pharmaceutical Co Net Margin % Historical Data

The historical data trend for Takeda Pharmaceutical Co's Net Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Net Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 6.45 1.34 11.76 6.45 7.87

Takeda Pharmaceutical Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Net Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 10.86 3.26 8.44 -4.60 9.51

Competitive Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Takeda Pharmaceutical Co's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Takeda Pharmaceutical Co Net Margin % Distribution

For the Drug Manufacturers industry and Healthcare sector, Takeda Pharmaceutical Co's Net Margin % distribution charts can be found below:

* The bar in red indicates where Takeda Pharmaceutical Co's Net Margin % falls into.



Takeda Pharmaceutical Co Net Margin % Calculation

Net margin - also known as net profit margin is the ratio of Net Income divided by net sales or Revenue, usually presented in percent.

Takeda Pharmaceutical Co's Net Margin for the fiscal year that ended in Mar. 2023 is calculated as

Net Margin=Net Income (A: Mar. 2023 )/Revenue (A: Mar. 2023 )
=317017/4027478
=7.87 %

Takeda Pharmaceutical Co's Net Margin for the quarter that ended in Dec. 2023 is calculated as

Net Margin=Net Income (Q: Dec. 2023 )/Revenue (Q: Dec. 2023 )
=105720/1111186
=9.51 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Takeda Pharmaceutical Co  (TSE:4502) Net Margin % Explanation

Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.

But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.


Takeda Pharmaceutical Co Net Margin % Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Net Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Takeda Pharmaceutical Co (TSE:4502) Business Description

Address
1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (TSE:4502) Headlines

No Headlines